Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A clinician’s handbook for using ctDNA throughout the patient journey
Samantha O. Hasenleithner, Michael R. Speicher
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 112
Practical recommendations for using ctDNA in clinical decision making
Stacey A. Cohen, Minetta C. Liu, Alexey Aleshin
Nature (2023) Vol. 619, Iss. 7969, pp. 259-268
Closed Access | Times Cited: 63
Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 56
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 36
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
Phillip G. Febbo, Mina Alsaraf Allo, Emma B. Alme, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 17
Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology
Kate E. Stanley, Tatjana Jatsenko, Stefania Tuveri, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Use of ctDNA in early breast cancer: analytical validity and clinical potential
François Panet, Andri Papakonstantinou, María Borrell, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples
Hatim Husain, Dean C. Pavlick, Bernard J. Fendler, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 54
Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
Xiaosha Wen, Huijie Pu, Quan Liu, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6025-6025
Open Access | Times Cited: 38
Real-Time Nanopore Q20+ Sequencing Enables Extremely Fast and Accurate Core Genome MLST Typing and Democratizes Access to High-Resolution Bacterial Pathogen Surveillance
Gabriel E. Wagner, Johanna Dabernig‐Heinz, Michaela Lipp, et al.
Journal of Clinical Microbiology (2023) Vol. 61, Iss. 4
Open Access | Times Cited: 31
Liquid biopsy in lung cancer
Lan Li, Haixia Jiang, Bingjie Zeng, et al.
Clinica Chimica Acta (2024) Vol. 554, pp. 117757-117757
Closed Access | Times Cited: 7
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
Elena Zaikova, Brian Yu Chieh Cheng, Viviana Cerda, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer
Gillian Vandekerkhove, Veda N. Giri, Susan Halabi, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 6
Prognostic Value of Residual Circulating Tumor DNA in Metastatic Pancreatic Ductal Adenocarcinoma
Hongkyung Kim, Jinho Lee, Mi Ri Park, et al.
Annals of Laboratory Medicine (2025) Vol. 45, Iss. 2, pp. 199-208
Open Access
A scoping review of factors influencing the implementation of liquid biopsy for cancer care
S. Sheriff, Maree Saba, R Patel, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The Future of Precision Oncology
Stuart L. Rulten, Richard Grose, Susanne A. Gatz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12613-12613
Open Access | Times Cited: 18
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA
Amanda Frydendahl, Mads Heilskov Rasmussen, Sarah Østrup Jensen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4252-4252
Open Access | Times Cited: 5
Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma
Karl Payne, Peter Brotherwood, Harini Suriyanarayanan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The Role of Cell-Free DNA in Cancer Treatment Decision Making
András Telekes, Anna Horváth
Cancers (2022) Vol. 14, Iss. 24, pp. 6115-6115
Open Access | Times Cited: 21
Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Krystle A. Lang Kuhs, J. Chad Brenner, F. Christopher Holsinger, et al.
JAMA Oncology (2023) Vol. 9, Iss. 12, pp. 1716-1716
Closed Access | Times Cited: 13
Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis
Min Liang, Jinghua Chen, Meihong Yu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 408-408
Open Access | Times Cited: 12
Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
Liam J. Brockley, Vanessa G. P. Souza, Aisling Forder, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2275-2275
Open Access | Times Cited: 11
Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review
Hugo C. Temperley, Timothy Fannon, Niall J. O’Sullivan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4005-4005
Open Access | Times Cited: 3
NGS method for parallel processing of high quality, damaged or fragmented input material using target enrichment
Anna Lyander, Anna Gellerbring, Moa Hägglund, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0304411-e0304411
Open Access | Times Cited: 3
Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
Denis Horgan, Tanja Čufer, Francesco Gatto, et al.
Healthcare (2022) Vol. 10, Iss. 9, pp. 1714-1714
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top